The evolving role of pharma on social media

Pharma companies are increasingly active on Twitter around medical meetings, but risk crowding out other conversations from independent medical experts with the ‘noise’ of industry tweets. In an Expert View piece, Annie Sullivan, director of corporate social media at Anglo-Swedish pharma major AstraZeneca (LSE: AZN), discusses the company’s novel approach of being 'a better social media citizen' and how its adoption of this strategy at the ASCO Annual Meeting in 2017 may help evolve the role of pharma on social media.

Social media, particularly Twitter, comes alive at medical meetings. Discussions online mirror the huddled conversations in the hallways of exhibition centers between researchers, patients, doctors and pharmaceutical companies. It’s a valuable resource for followers around the world who can't attend, or for those in the conference center to make connections that may not otherwise happen.

Responding to feedback